Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases

Transfusion

Volumn 39, Issue 7, 1999, Pages 763-771

  Schonewille, Henk ^a   Haak, H L ^a   Van Zijl, A M ^a  

^a LEYENBURG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BLOOD BANK; BLOOD COMPATIBILITY; BLOOD TRANSFUSION; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; FEMALE; HUMANS; ISOANTIBODIES; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES;

EID: 0032769758     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39070763.x     Document Type: Article

References (53)

1. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patient populations. Transfusion 1981;21:462-6.
2. Blumberg N, Peck K, Ross K, et al. Immune response to chronic red blood cell transfusion. Vox Sang 1983;44:212-7.
3. Lasky LC, Rose RR, Polesky HF. Incidence of antibody formation and positive direct antiglobulin tests in a multitransfused hemodialysis population. Transfusion 1984;24:198-200.
4. 0 (D)? Vox Sang 1984;47:205-8.
5. Floss AM, Strauss RG, Goeken N, et al. Multiple transfusions fail to provoke antibodies against blood cell antigens in human infants. Transfusion 1986;26:419-22.
6. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, et al. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. Vox Sang 1987;52:95-8.
7. Brantley SG, Ramsey G. Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion 1988;24:463-6.
8. Wakui H, Tada I, Kimura Y, et al. Unusual occurrence of six anti-erythrocyte alloantibodies in an Rh(D)-negative man with myelodysplastic syndrome. Jpn J Med 1989;28:736-9.
9. Seyfried H, Walewska I. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Mater Med Pol 1990;22:21-5.
10. Spanos T, Karageorga M, Ladis V, et al. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58:50-5.
11. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. Blood 1990;76:1431-7.
12. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990;30:532-5.
13. Hmida S, Mojaat N, Maamar M, et al. Red cell alloantibodies in patients with haemoglobinopathies. Nouv Rev Fr Hematol 1994;36:363-6.
14. Mohandas K, Aledort L. Transfusion requirements, risks, and costs for patients with malignancy. Transfusion 1995;35:427-30.
15. Ramsey G, Smietana SJ. Multiple or uncommon red cell alloantibodies in women: association with autoimmune disease. Transfusion 1995;35:582-6.
16. Heddle NM, Soutar RL, O'Hoski PL, et W. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995;91:1000-5.
17. Moreira G Jr, Bordin JO, Kuroda A, et al. Red blood cell alloimmunization in sickle cell disease; the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol 1996;52:197-200.
18. Redman M, Regan F, Contreras M. A prospective study of the incidence of red cell alloimmunization following transfusion. Vox Sang 1996;71:216-20.
19. Quijada JG. Post-transfusion alloimmunization (letter). Br J Haematol 1996;95:573-4.
20. Ramsey G, Larson P. Loss of red cell alloantibodies over time. Transfusion 1988;28:162-5.
21. Ramsey G, Smietana SJ. Long-term follow-up testing of red cell alloantibodies. Transfusion 1994;34:122-4.
22. Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562-9.
23. Forbes JM, Anderson MD, Anderson GF, et al. Blood transfusion costs: a multicenter study. Transfusion 1991;31:318-23.
24. Dutcher JP, Schiffer CA, Aisner J, et al. Long-term follow-up of patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized. Blood 1981;58:1007-11.
25. Lichtiger B, Perry-Thornton E. Hemolytic transfusion reactions in oncology patients: experience in a large cancer center. J Clin Oncol 1984;2:438-42.
26. Holohan TV, Terasaki PI, Deisseroth AB. Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood 1981;58:122-8.
27. Lichtiger B, Hester JP. Transfusion of Rh-incompatible blood components to cancer patients. Haematologia 1986;19:81-8.
28. Huh YO, Lichtiger B. Transfusion reactions in patients with cancer. Am J Clin Pathol 1987;87:253-7.
29. Wernet D, Weiss B, Schmidt H, et al. Antigen-independent reactivation of anti-E, years after allogeneic bone marrow transplantation: a case report. Br J Haematol 1995;91:758-60.
30. Abou-Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995;35:931-5.
31. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
32. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99.
33. Walker RH, Lin DT, Hartrick MB. Alloimmunization following blood transfusion. Arch Pathol Lab Med 1989;113:254-61.
34. Chow MP, Hu HY, Lyou JY, et al. Red cells, HLA and platelet antibody formation in patients with multiple transfusions. Acta Haematol 1994;92:57-60.
35. Hoeltge GA, Domen RE, Rybicki LA, et al. Multiple red cell transfusions and alloimmunization. Experiences with 6,996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42-5.
36. Mollison PI, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell, 1993.
37. Wijermans PW, Gerrits WB, Haak HL. Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 1993;50:292-6.
38. Zulian G, Roux E, Tiercy JM, et al. Transfusion-associated graft-versus-host disease (TGVHD) in a patient treated with cladribine (2-CDA, 2-chlorodeoxyadenosine) demonstrated by PCR amplification of DNA mini-satellites and HLA-DR oligo-typing (abstract). Br J Haematol 1994;87(Suppl 1):77.
39. Maung ZT, Wood AC, Jackson GH, et al. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 1994;88:649-52.
40. Williamson LM. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. British Committee for Standards in Haematology Transfusion Task Force. Transfus Med 1996;6:261-71.
41. 1 patients who present with anti-E. Transfusion 1994;34:756-8.
42. Giblett ER. A critique of the theoretical hazard of inter-vs. infra-racial transfusion. Transfusion 1961;1:233-8.
43. Havemann H, Lichtiger B. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review. Cancer 1992;69:252-5.
44. Vamvakas EC, Pineda AA, Reisner R, et al. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 1995;35:26-32.
45. Blumberg N, Triulzi DJ, Heal JM. Transfusion-induced immunomodulation and its clinical consequences. Transfus Med Rev 1990;4(Suppl 1):24-35.
46. Smith DMJr. Immunosuppressive effects of blood transfu-sion. Clin Lab Med 1992;12:723-41.
47. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-9.
48. Huestis DW, Glaser L. The neutrophil in transfusion medicine. Transfusion 1994;34:630-46.
49. Quintiliani L, Buzzonetti A, DiGirolamo M, et al. Effects of blood transfusion on the immune responsiveness and survival of cancer patients: a prospective study. Transfusion 1991;31:713-8.
50. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996;101:299-308.
51. Dzik S, Blajchman MA, Blumberg N, et al. Current research on the immunomodulatory effect of allogeneic blood trans-fusion. Vox Sang 1996;70:187-94.
52. Dunstan RA, Simpson MB, Rosse WF. Erythrocyte antigens on human platelets. Absence of the Rh, Duffy, Kell, Kidd and Lutheran antigens. Transfusion 1984;24:243-6.
53. Woodrow JC, Donahue WT. Rh immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. Br Med J 1968;4:139-44.